Recursion Pharmaceuticals (NASDAQ: RXRX) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Gibson highlighted, "Recursion has a tremendous amount of potential catalysts coming in the next 18 months," referencing the pipeline, partnerships, and platform advancements. He reported, "a pro ...

Operating massive reverse proxy fleets reveals hard lessons: optimizations that work on smaller systems fail at scale; mundane oversights like missing commas cause major outages; and abstractions ...

GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Kurt Schlosser on Oct 15, 2025 at ...

Scientists are reporting the first compelling evidence in people that cognitive training can boost levels of a brain chemical that typically declines with age. A 10-week study of people 65 or older ...

Under the category of careers that are, or will be, impacted, by artificial intelligence, attorneys are inevitably on it. Here’s a tale of a lawyer caught using AI while explaining to the Court why he ...

The London property market is in crisis with "nothing like enough new homes being built", forcing the government to water down targets for affordable housing, the cabinet minister in charge has told ...

A hospital has carried out a record number of prostate procedures to reduce NHS waiting lists. Enlarged prostate is a common non-cancerous condition that affects older men. Also known as benign ...